FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000473911> ?p ?o ?g. }

• W2000473911 endingPage "856" @default.
• W2000473911 startingPage "848" @default.
• W2000473911 abstract "The U.S. National Institutes of Health through the National Cancer Institute (NCI) have been charged with the goal of eliminating death and suffering from cancer by the year 2015. In order to achieve this very ambitious goal, the development of novel nanotechnology-based devices and therapeutics that are capable of one or more clinically important functions is envisioned. There is great hope and expectation in the development of theranostic nanocarriers, which combine diagnostic and therapeutic agents in one entity. Main delivery approaches include prodrugs, liposomes, polymersomes, and polymeric micelles and nanoparticles. Diagnostic and therapeutic agents are physically entrapped or conjugated to the nanocarriers, or they are conjugated to carefully designed polymers which subsequently form nanocarriers. This focus discusses pros and cons of the different theranostic approaches and tries to answer the question which approach has the highest probability to translate into the clinic and benefit patients. Carefully designed polymers, conjugated with diagnostic and therapeutic agents, that either self-assemble or can be processed to form nanocarriers offer clear advantages over random physical entrapment or conjugation of these agents to existing nanocarriers. These polymers can optionally be fitted with terminal stabilizing or anchoring functionalities and a targeting ligand. However, the need for nanocarriers that are subjected to the enhanced permeability and retention (EPR) effect to carry ligands for active targeting still needs to be demonstrated. Thirty-seven of the 41 nanocarrier-based formulations that are on the market or are under investigation at different levels of clinical development rely on passive targeting. The answer to the title question, not surprisingly, can only be no, but very promising approaches are being developed that have the potential to translate into the clinic and meet regulatory requirements." @default.
• W2000473911 created "2016-06-24" @default.
• W2000473911 creator A5076883794 @default.
• W2000473911 date "2013-02-04" @default.
• W2000473911 modified "2023-10-17" @default.
• W2000473911 title "Theranostics: Are We There Yet?" @default.
• W2000473911 cites W1832646591 @default.
• W2000473911 cites W1963664144 @default.
• W2000473911 cites W1963977788 @default.
• W2000473911 cites W1965063429 @default.
• W2000473911 cites W1970546052 @default.
• W2000473911 cites W1975473350 @default.
• W2000473911 cites W1982037325 @default.
• W2000473911 cites W1982823397 @default.
• W2000473911 cites W1986168639 @default.
• W2000473911 cites W1993638883 @default.
• W2000473911 cites W1995678063 @default.
• W2000473911 cites W1999564702 @default.
• W2000473911 cites W2000928953 @default.
• W2000473911 cites W2008648326 @default.
• W2000473911 cites W2008897820 @default.
• W2000473911 cites W2019880908 @default.
• W2000473911 cites W2031428283 @default.
• W2000473911 cites W2031963388 @default.
• W2000473911 cites W2034717709 @default.
• W2000473911 cites W2035697316 @default.
• W2000473911 cites W2043962829 @default.
• W2000473911 cites W2049721678 @default.
• W2000473911 cites W2051240132 @default.
• W2000473911 cites W2051469607 @default.
• W2000473911 cites W2052634515 @default.
• W2000473911 cites W2053360422 @default.
• W2000473911 cites W2057214019 @default.
• W2000473911 cites W2057255825 @default.
• W2000473911 cites W2059370215 @default.
• W2000473911 cites W2060713279 @default.
• W2000473911 cites W2070609818 @default.
• W2000473911 cites W2072139355 @default.
• W2000473911 cites W2073603954 @default.
• W2000473911 cites W2075512377 @default.
• W2000473911 cites W2077085160 @default.
• W2000473911 cites W2082902103 @default.
• W2000473911 cites W2085043731 @default.
• W2000473911 cites W2086415594 @default.
• W2000473911 cites W2087470550 @default.
• W2000473911 cites W2087854516 @default.
• W2000473911 cites W2089693485 @default.
• W2000473911 cites W2094607644 @default.
• W2000473911 cites W2099380717 @default.
• W2000473911 cites W2102108277 @default.
• W2000473911 cites W2106530175 @default.
• W2000473911 cites W2130797462 @default.
• W2000473911 cites W2139702993 @default.
• W2000473911 cites W2139892955 @default.
• W2000473911 cites W2144163864 @default.
• W2000473911 cites W2144794900 @default.
• W2000473911 cites W2152673204 @default.
• W2000473911 cites W2154335294 @default.
• W2000473911 cites W2316142734 @default.
• W2000473911 cites W2322174213 @default.
• W2000473911 cites W2328126029 @default.
• W2000473911 cites W2330319662 @default.
• W2000473911 cites W2492194066 @default.
• W2000473911 cites W4211199440 @default.
• W2000473911 doi "https://doi.org/10.1021/mp300644n" @default.
• W2000473911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23379301" @default.
• W2000473911 hasPublicationYear "2013" @default.
• W2000473911 type Work @default.
• W2000473911 sameAs 2000473911 @default.
• W2000473911 citedByCount "138" @default.
• W2000473911 countsByYear W20004739112013 @default.
• W2000473911 countsByYear W20004739112014 @default.
• W2000473911 countsByYear W20004739112015 @default.
• W2000473911 countsByYear W20004739112016 @default.
• W2000473911 countsByYear W20004739112017 @default.
• W2000473911 countsByYear W20004739112018 @default.
• W2000473911 countsByYear W20004739112019 @default.
• W2000473911 countsByYear W20004739112020 @default.
• W2000473911 countsByYear W20004739112021 @default.
• W2000473911 countsByYear W20004739112022 @default.
• W2000473911 countsByYear W20004739112023 @default.
• W2000473911 crossrefType "journal-article" @default.
• W2000473911 hasAuthorship W2000473911A5076883794 @default.
• W2000473911 hasConcept C112613896 @default.
• W2000473911 hasConcept C15920480 @default.
• W2000473911 hasConcept C171250308 @default.
• W2000473911 hasConcept C178790620 @default.
• W2000473911 hasConcept C18150654 @default.
• W2000473911 hasConcept C185592680 @default.
• W2000473911 hasConcept C192562407 @default.
• W2000473911 hasConcept C2779820397 @default.
• W2000473911 hasConcept C51115888 @default.
• W2000473911 hasConcept C521977710 @default.
• W2000473911 hasConcept C67407626 @default.
• W2000473911 hasConceptScore W2000473911C112613896 @default.
• W2000473911 hasConceptScore W2000473911C15920480 @default.
• W2000473911 hasConceptScore W2000473911C171250308 @default.
• W2000473911 hasConceptScore W2000473911C178790620 @default.

• next